Association between multi inflammatory index and heart failure in patients with coronary heart disease: a RCSCD-TCM

Yuanyuan He1, Tong Yang1, Yuting Li1

  • 1Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, China.

Insights

The multi-inflammatory index (MII) is associated with heart failure (HF) risk in coronary heart disease (CHD) patients. MII-1 demonstrated the strongest association, particularly in women and those with hypertension or diabetes.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Public Health

Background:

  • Anti-inflammatory therapy presents a potential therapeutic target for heart failure (HF).
  • The multi-inflammatory index (MII), a composite measure of inflammation, requires further investigation regarding its association with HF.
  • The precise relationship between MII and HF in coronary heart disease (CHD) patients remains unclear.

Purpose of the Study:

  • To investigate the association between the multi-inflammatory index (MII) and the risk of heart failure (HF).
  • To examine this association specifically within a cohort of patients diagnosed with coronary heart disease (CHD).

Main Methods:

  • A cohort study involving 17,937 CHD patients, with 6,386 diagnosed with HF.
  • Logistic regression analysis was employed to assess the relationship between MII and HF.
  • Subgroup analyses were conducted based on sex, blood pressure, and blood glucose levels.

Main Results:

  • MII-1 showed the highest odds ratio (OR: 1.33) for HF compared to other MII tertiles.
  • The association between MII-1 and HF was stronger in females than males.
  • MII-1 was significantly associated with increased HF risk in CHD patients with hypertension (OR: 1.06) and diabetes (OR: 1.04).

Conclusions:

  • The multi-inflammatory index (MII) is significantly associated with heart failure (HF) risk in coronary heart disease (CHD) patients.
  • The association between MII and HF risk was more pronounced in women.
  • MII-1 emerged as a superior indicator of HF risk in this patient population.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
707
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
321
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
420
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
510
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730